Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Dual tracer 99mTc-pertechnetate/99mTc-MIBI dual-time-point SPECT/CT parathyroid gland assessment regarding to parathyroid gland size and biochemical parameters - two years single imaging centre experience

E. Krčálová, J. Horáček, E. Nováková, M. Cvejn, D. Lazaráková, R. Mikulecký, J. Máslo, J. Čepková, J. Tilšer, J. Doležal

. 2019 ; 62 (1) : 1-5.

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19030732

Grant support
PROGRES Q40-14 Univerzita Karlova v Praze

INTRODUCTION: Preoperative parathyroid imaging is inevitable part of focused parathyroid surgery. The aim of our study was assessment of parathyroid scintigraphy diagnostic accuracy regarding to size and metabolic parameters of hyperfunctioning parathyroid tissue. MATERIAL AND METHODS: Parathyroid scintigraphy for suspected primary hyperparathyroidism was performed in 95 patients during years 2015 and 2016. Of them, 75 patients with known clinical outcome (40 underwent surgery, 35 had documented laboratory follow-up) were further retrospectively evaluated. The performance of dual tracer 99mTc-pertechnetate and 99mTc-MIBI subtraction and dual-time-point 99mTc-MIBI imaging with SPECT/CT was analysed. Serum parathyroid hormone (PTH), calcaemia, ionized calcaemia and phosphataemia and ultrasound detected adenoma volume and largest diameter in false negative and true positive findings were compared using Mann-Whitney test. RESULTS: Sensitivity and specificity of parathyroid scintigraphy was 74.5% and 95.8%, respectively. NPV was 63.8% and PPV 97.4%. Hyperfunctioning parathyroid tissue detectability was almost significantly associated with hypophosphataemia and PTH levels. CONCLUSION: Parathyroid scintigraphy provides high sensitivity and superior specificity in parathyroid adenoma location, nevertheless the diagnostic accuracy tends to decline in smaller adenomas and in less metabolically active parathyroid tissue causing only subtle biochemical changes. 18F-Fluorocholine PET/CT or 3D SPECT/CT subtraction should be a reasonable option for those cases.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19030732
003      
CZ-PrNML
005      
20200514101344.0
007      
ta
008      
190902s2019 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2019.38 $2 doi
035    __
$a (PubMed)30931889
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Krčálová, Eva $7 xx0247834 $u Academic Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic; Nuclear Medicine Department, University Hospital Hradec Králové, Czech Republic
245    10
$a Dual tracer 99mTc-pertechnetate/99mTc-MIBI dual-time-point SPECT/CT parathyroid gland assessment regarding to parathyroid gland size and biochemical parameters - two years single imaging centre experience / $c E. Krčálová, J. Horáček, E. Nováková, M. Cvejn, D. Lazaráková, R. Mikulecký, J. Máslo, J. Čepková, J. Tilšer, J. Doležal
504    __
$a Literatura
520    9_
$a INTRODUCTION: Preoperative parathyroid imaging is inevitable part of focused parathyroid surgery. The aim of our study was assessment of parathyroid scintigraphy diagnostic accuracy regarding to size and metabolic parameters of hyperfunctioning parathyroid tissue. MATERIAL AND METHODS: Parathyroid scintigraphy for suspected primary hyperparathyroidism was performed in 95 patients during years 2015 and 2016. Of them, 75 patients with known clinical outcome (40 underwent surgery, 35 had documented laboratory follow-up) were further retrospectively evaluated. The performance of dual tracer 99mTc-pertechnetate and 99mTc-MIBI subtraction and dual-time-point 99mTc-MIBI imaging with SPECT/CT was analysed. Serum parathyroid hormone (PTH), calcaemia, ionized calcaemia and phosphataemia and ultrasound detected adenoma volume and largest diameter in false negative and true positive findings were compared using Mann-Whitney test. RESULTS: Sensitivity and specificity of parathyroid scintigraphy was 74.5% and 95.8%, respectively. NPV was 63.8% and PPV 97.4%. Hyperfunctioning parathyroid tissue detectability was almost significantly associated with hypophosphataemia and PTH levels. CONCLUSION: Parathyroid scintigraphy provides high sensitivity and superior specificity in parathyroid adenoma location, nevertheless the diagnostic accuracy tends to decline in smaller adenomas and in less metabolically active parathyroid tissue causing only subtle biochemical changes. 18F-Fluorocholine PET/CT or 3D SPECT/CT subtraction should be a reasonable option for those cases.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a primární hyperparatyreóza $x diagnostické zobrazování $x patologie $7 D049950
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a paratyreoidea $x diagnostické zobrazování $x patologie $7 D010280
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a SPECT/CT $x metody $7 D000072098
650    _2
$a 99mTc-technecistan sodný $x terapeutické užití $7 D013670
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
700    1_
$a Horáček, Jiří, $d 1952- $7 nlk19990073252 $u Academic Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic; 4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic
700    1_
$a Nováková, Edita, $d 1969- $7 xx0239967 $u Náchod Hospital Internal Medicine Department, Czech Republic
700    1_
$a Cvejn, Miroslav $7 xx0105256 $u Private Endocrinology Outpatient Clinic, Náchod, Czech Republic
700    1_
$a Lazaráková, Daša $7 xx0239981 $u Pardubice Hospital Internal Medicine Department, Czech Republic
700    1_
$a Mikulecký, Radek $7 xx0239965 $u Pardubice Hospital Internal Medicine Department, Czech Republic
700    1_
$a Máslo, Jiří $7 _AN068144 $u Náchod Hospital Osteology Outpatient Clinic, Czech Republic
700    1_
$a Čepková, Jitka $7 xx0146677 $u Department of Clinical Biochemistry, Faculty of Medicine Hradec Králové and University Hospital Hradec Králové
700    1_
$a Tilšer, Jan $7 xx0239986 $u Nuclear Medicine Department, University Hospital Hradec Králové, Czech Republic
700    1_
$a Doležal, Jiří, $d 1969- $7 xx0052087 $u Nuclear Medicine Department, University Hospital Hradec Králové, Czech Republic
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 62, č. 1 (2019), s. 1-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30931889 $y Pubmed
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/am_2019062010001.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 4 $z 0
990    __
$a 20190902 $b ABA008
991    __
$a 20200514101340 $b ABA008
999    __
$a ok $b bmc $g 1444085 $s 1069221
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 62 $c 1 $d 1-5 $i 1805-9694 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
GRA    __
$a PROGRES Q40-14 $p Univerzita Karlova v Praze
LZP    __
$b NLK118 $a Pubmed-20190902

Find record

Citation metrics

Archiving options